CA1303032C - Nucleosides antiviraux - Google Patents

Nucleosides antiviraux

Info

Publication number
CA1303032C
CA1303032C CA000556981A CA556981A CA1303032C CA 1303032 C CA1303032 C CA 1303032C CA 000556981 A CA000556981 A CA 000556981A CA 556981 A CA556981 A CA 556981A CA 1303032 C CA1303032 C CA 1303032C
Authority
CA
Canada
Prior art keywords
azido
deoxythymidine
ester
salt
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA000556981A
Other languages
English (en)
Inventor
Janet Litster Rideout
David Walter Barry
Sandra Nusinoff Lehrman
Martha Heider St. Clair
Phillip Allen Furman
George Andrew Freeman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858506869A external-priority patent/GB8506869D0/en
Priority claimed from GB858511774A external-priority patent/GB8511774D0/en
Priority claimed from US06/776,899 external-priority patent/US4724232A/en
Priority claimed from GB858523881A external-priority patent/GB8523881D0/en
Priority claimed from GB868603450A external-priority patent/GB8603450D0/en
Priority claimed from CA000504126A external-priority patent/CA1238277A/fr
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Priority to CA000616284A priority Critical patent/CA1340519C/fr
Application granted granted Critical
Publication of CA1303032C publication Critical patent/CA1303032C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA000556981A 1985-03-16 1988-01-20 Nucleosides antiviraux Expired - Lifetime CA1303032C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA000616284A CA1340519C (fr) 1985-03-16 1992-01-13 Nucleosides antiviraux

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
GB858506869A GB8506869D0 (en) 1985-03-16 1985-03-16 Antiviral compound
GB8506869 1985-03-16
GB8511774 1985-05-09
GB858511774A GB8511774D0 (en) 1985-05-09 1985-05-09 Antiviral compounds
US776,899 1985-09-17
US06/776,899 US4724232A (en) 1985-03-16 1985-09-17 Treatment of human viral infections
GB858523881A GB8523881D0 (en) 1985-09-27 1985-09-27 Antiviral compounds
GB8523881 1985-09-27
GB868603450A GB8603450D0 (en) 1986-02-12 1986-02-12 Antiviral compounds
GB8603450 1986-02-12
CA000504126A CA1238277A (fr) 1985-03-16 1986-03-14 Nucleosides antiviraux

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA000504126A Division CA1238277A (fr) 1985-03-16 1986-03-14 Nucleosides antiviraux

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA000616284A Division CA1340519C (fr) 1985-03-16 1992-01-13 Nucleosides antiviraux

Publications (1)

Publication Number Publication Date
CA1303032C true CA1303032C (fr) 1992-06-09

Family

ID=27543346

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000556981A Expired - Lifetime CA1303032C (fr) 1985-03-16 1988-01-20 Nucleosides antiviraux

Country Status (1)

Country Link
CA (1) CA1303032C (fr)

Similar Documents

Publication Publication Date Title
EP0196185A2 (fr) Nucléosides antiviraux
CA1285935C (fr) Nucleosides therapeutiques
US4963662A (en) Fluorinated nucleosides and method for treating retrovirus infections therewith
EP0206497B1 (fr) Nucléosides thérapeutiques et leur préparation
CA2143107C (fr) .beta.-d-dioxolane-nucleosides, enantiomeres purs
EP1600448A2 (fr) Nucléosides de béta-D-Dioxolane énantiomériquement Purs
EP0317128B1 (fr) Pyrimidine Nucléosides Anti-HIV
EP0306597B1 (fr) Nucléosides antiviraux
US5559100A (en) Methods of treating hepatitis B virus infection with therapeutic nucleosides
US5153180A (en) Fluorinated nucleosides and process for treating retrovirus infections therewith
CA1303032C (fr) Nucleosides antiviraux
JPH047726B2 (fr)
CA1340519C (fr) Nucleosides antiviraux
IE880209L (en) Pharmaceutical formulation
NZ224007A (en) 3'-azido-3'-deoxythymidine derivatives as antiviral agents
WO1988009332A1 (fr) Nucleosides a usage therapeutique
CA1327005C (fr) Nucleosides therapeutiques
DK175122B1 (da) Farmaceutisk præparat omfattende et farmaceutisk acceptabelt derivat af 3'azido-3'-desoxythymidin samt fremgangsmåde til fremstilling deraf
HU220611B1 (hu) Nukleozidok foszfolipidszármazékai, ezeket hatóanyagként tartalmazó gyógyszerkészítmények és az előállításukra szolgáló eljárások
IL85096A (en) Use of 3'-azido-3'- deoxythymidine in the treatment of prophylaxis of human retrovirus infection

Legal Events

Date Code Title Description
MKEX Expiry